Reducing insulin resistance, improving intestinal barrier function, inhibiting endotoxemia, and regulating gut microbiota dysbiosis.Inhibition of macrophage apoptosis and improvement of endoplasmic reticulum stress via the Bcl-2/Bax/Caspase3 signaling pathway. The gene discussed is BCL2; the disease is serum lipopolysaccharide activity.